UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 27, 2022
Accession Number:
0001213900-22-029644
Submission Type:
POS AM
CIK:
0001415397
Company Name:
Raphael Pharmaceutical Inc.
File Number:
333-260766